Literature DB >> 17465776

Role of a paracrine action of mesenchymal stem cells in the improvement of left ventricular function after coronary artery occlusion in rats.

Wangde Dai1, Sharon L Hale, Robert A Kloner.   

Abstract

PURPOSE: We aimed to determine whether soluble factors released by cultured mesenchymal stem cells (MSCs) improved cardiac function in an experimental model of myocardial infarction.
METHODS: MSCs were cultured in fresh medium. The conditioned medium, which contained factors secreted by MSCs, was collected after 4 days of culture. Fischer rats with 1-week-old myocardial infarction were divided into four groups that received: saline (n = 12); fresh medium (n = 10); conditioned medium (n = 8); or 2 million MSCs in fresh medium (n = 10) by direct intramyocardial injection. A total of 4 weeks later, left ventricular (LV) function was assessed by LV angiogram and by LV catheterization. Hearts were processed for histology.
RESULTS: Before treatment, LV angiogram assessment demonstrated that the baseline LV function was comparable among the four groups. At 4 weeks after treatment, LV angiogram and LV catheterization showed that LV ejection fraction was better in the fresh medium (49.5 +/- 1.0%), conditioned medium (48.5 +/- 2.1%) and MSCs groups (49.9 +/- 4.2%) than in the saline group (43.7 +/- 1.2%; p < 0.05). There were no significant differences in heart rate, blood pressure, postmortem LV volume, infarct size or septum thickness among the groups. The scar thickness was similar in the saline (395 +/- 31 microm), fresh medium (404 +/- 30 microm) and conditioned medium (397 +/- 34 microm) groups, but significantly thicker in the MSCs group (560 +/- 51 microm; p < 0.05).
CONCLUSION: Fresh medium, conditioned medium and MSC injection all improved LV function at 4 weeks after treatment compared with saline treatment in a rat myocardial infarct model; only MSCs increased wall thickness. Since the culture medium contains nutrients and bovine serum, the roles of the soluble factors released by MSCs might be masked. The effect of these nutrients needs further investigation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17465776     DOI: 10.2217/17460751.2.1.63

Source DB:  PubMed          Journal:  Regen Med        ISSN: 1746-0751            Impact factor:   3.806


  35 in total

Review 1.  Stem cells in the infarcted heart.

Authors:  Dinender K Singla
Journal:  J Cardiovasc Transl Res       Date:  2009-11-20       Impact factor: 4.132

2.  New therapies for reducing post-myocardial left ventricular remodeling.

Authors:  Robert A Kloner; Jianru Shi; Wangde Dai
Journal:  Ann Transl Med       Date:  2015-02

3.  Stem Cell Therapy for Myocardial Infarction 2001-2013 Revisited.

Authors:  Christoph Edlinger; Catharina Schreiber; Bernhard Wernly; Alexandra Anker; Katja Ruzicka; Christian Jung; Uta C Hoppe; Michael Lichtenauer
Journal:  Stem Cell Rev Rep       Date:  2015-10       Impact factor: 5.739

4.  Mesenchymal stem cell-derived extracellular vesicles and retinal ischemia-reperfusion.

Authors:  Biji Mathew; Sriram Ravindran; Xiaorong Liu; Leianne Torres; Mohansrinivas Chennakesavalu; Chun-Chieh Huang; Liang Feng; Ruth Zelka; Jasmine Lopez; Monica Sharma; Steven Roth
Journal:  Biomaterials       Date:  2019-01-09       Impact factor: 12.479

5.  Cellular therapy for repair of cardiac damage after acute myocardial infarction.

Authors:  Matthew M Cook; Katarina Kollar; Gary P Brooke; Kerry Atkinson
Journal:  Int J Cell Biol       Date:  2009-03-29

6.  Myocardial oxygenation and functional recovery in infarct rat hearts transplanted with mesenchymal stem cells.

Authors:  Simi M Chacko; Mahmood Khan; M Lakshmi Kuppusamy; Ramasamy P Pandian; Saradhadevi Varadharaj; Karuppaiyah Selvendiran; Anna Bratasz; Brian K Rivera; Periannan Kuppusamy
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-03-13       Impact factor: 4.733

7.  Sustained therapeutic perfusion outside transplanted sites in chronic myocardial infarction after stem cell transplantation.

Authors:  Pablo Maureira; Pierre-Yves Marie; Yihua Liu; Fengxu Yu; Sylvain Poussier; Fatiha Maskali; Frederique Groubatch; Gilles Karcher; Nguyen Tran
Journal:  Int J Cardiovasc Imaging       Date:  2013-02-13       Impact factor: 2.357

8.  Genetically Engineered Mesenchymal Stem Cells Influence Gene Expression in Donor Cardiomyocytes and the Recipient Heart.

Authors:  Mary Kearns-Jonker; Wangde Dai; Mirja Gunthart; Tania Fuentes; Hsiao-Yun Yeh; Paul Gerczuk; Martin Pera; Christine Mummery; Robert A Kloner
Journal:  J Stem Cell Res Ther       Date:  2012-06-07

9.  Harnessing Epicardial Progenitor Cells and Their Derivatives for Rescue and Repair of Cardiac Tissue After Myocardial Infarction.

Authors:  Krithika S Rao; Jeffrey L Spees
Journal:  Curr Mol Biol Rep       Date:  2017-07-15

10.  Evolving cell-based therapies for heart failure patients.

Authors:  Bruno K Podesser; Michael Bauer; Ronglih Liao
Journal:  Curr Treat Options Cardiovasc Med       Date:  2008-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.